This effect may still be amenable to immunomodulation, however, as tumor-specific CD8+ T cells from the peripheral blood of GC patients can still exert cytotoxicity following stimulation by peptide-pulsed cells in vitro3. This evidence concerns the gene CD8A and gastric cancer.